Department of Nursing, William Paterson University, Wayne, New Jersey, United States of America.
Division of Infectious Diseases, Saint Michael's Medical Center, Newark, New Jersey, United States of America.
PLoS One. 2020 Dec 29;15(12):e0244376. doi: 10.1371/journal.pone.0244376. eCollection 2020.
To determine rates of annual and durable retention in medical care and viral suppression among patients enrolled in the Peter Ho Clinic, from 2013-2017.
This is a retrospective review of medical record data in an urban clinic, located in Newark, New Jersey, a high prevalence area of persons living with HIV. Viral load data were electronically downloaded, in rolling 1-year intervals, in two-month increments, from January 1, 2013 to December 31, 2019. Three teams were established, and every two months, they were provided with an updated list of patients with virologic failure. Retention and viral suppression rates were first calculated for each calendar-year. After patients were determined to be retained/suppressed annually, the proportion of patients with durable retention and viral suppression were calculated in two, three, four, five and six-year periods. Descriptive statistics were used to summarize sample characteristics by retention in care, virologic failure and viral suppression with Pearson Chi-square; p-value <0.05 was statistically significant. Multiple logistic regression models identified patient characteristics associated with retention in medical care, virologic failure and suppression.
As of December 31, 2017, 1000 (57%) patients were retained in medical care of whom 870 (87%) were suppressed. Between 2013 and 2016, decreases in annual (85% to 77%) and durable retention in care were noted: two-year (72% to 70%) and three-year (63% to 59%) periods. However, increases were noted for 2017, in annual (89%) and durable retention in the two-year period (79%). In the adjusted model, when compared to current patients, retention in care was less likely among patients reengaging in medical care (adjusted Odds Ratio (aOR): 0.77, 95% CI: 0.61-0.98) but more likely among those newly diagnosed from 2014-2017 (aOR: 1.57, 95% CI: 1.08-2.29), compared to those in care since 2013. A higher proportion of patients re-engaging in medical care had virologic failure than current patients (56% vs. 47%, p < 0.0001). As age decreased, virologic failure was more likely (p<0.0001). Between 2013 and 2017, increases in annual (74% to 87%) and durable viral suppression were noted: two-year (59% to 73%) and three-year (49% to 58%) periods. Viral suppression was more likely among patients retained in medical care up to 2017 versus those who were not (aOR: 5.52, 95% CI: 4.08-7.46). Those less likely to be suppressed were 20-29 vs. 60 years or older (aOR: 0.52, 95% CI: 0.28-0.97), had public vs. private insurance (aOR: 0.29, 95% CI: 0.15-0.55) and public vs. private housing (aOR: 0.59, 95% CI: 0.40-0.87).
Restructuring clinical services at this urban clinic was associated with improved viral suppression. However, concurrent interventions to ensure retention in medical care were not implemented. Both retention in care and viral suppression interventions should be implemented in tandem to achieve an end to the epidemic. Retention in care and viral suppression should be measured longitudinally, instead of cross-sectional yearly evaluations, to capture dynamic changes in these indicators.
确定从 2013 年到 2017 年期间,在新泽西州纽瓦克市彼得·何诊所注册的患者的医疗保健年度和持久保留率以及病毒抑制率。
这是对位于新泽西州纽瓦克市的一家城市诊所的医疗记录数据进行的回顾性研究,该地区是艾滋病毒感染者高发地区。从 2013 年 1 月 1 日到 2019 年 12 月 31 日,每两个月以两个月为增量,从电子下载病毒载量数据。成立了三个团队,每个月都会收到一份更新的病毒学失败患者名单。首先计算每个日历年度的保留率和病毒抑制率。确定患者每年保留/抑制后,计算两年、三年、四年、五年和六年期间持久保留和病毒抑制的比例。使用 Pearson Chi-square 对保留在医疗保健、病毒学失败和病毒抑制方面的患者特征进行描述性统计分析;p 值<0.05 为统计学显著。多因素逻辑回归模型确定了与保留在医疗保健、病毒学失败和抑制相关的患者特征。
截至 2017 年 12 月 31 日,1000 名(57%)患者保留在医疗保健中,其中 870 名(87%)患者得到抑制。2013 年至 2016 年,年度(85%降至 77%)和持久保留率下降:两年(72%降至 70%)和三年(63%降至 59%)。然而,2017 年有所增加,年度(89%)和两年期(79%)持久保留率均有所增加。在调整模型中,与当前患者相比,重新接受医疗保健的患者保留率较低(调整后的优势比(aOR):0.77,95%置信区间:0.61-0.98),但与 2013 年以来接受治疗的患者相比,2014 年至 2017 年新诊断的患者更有可能(aOR:1.57,95%置信区间:1.08-2.29)。重新接受医疗保健的患者病毒学失败的比例高于当前患者(56%比 47%,p<0.0001)。随着年龄的降低,病毒学失败的可能性增加(p<0.0001)。2013 年至 2017 年,年度(74%至 87%)和持久病毒抑制率增加:两年(59%至 73%)和三年(49%至 58%)期间。与未保留在医疗保健中的患者相比,2017 年保留在医疗保健中的患者病毒抑制的可能性更大(aOR:5.52,95%置信区间:4.08-7.46)。不太可能被抑制的患者是 20-29 岁与 60 岁或以上(aOR:0.52,95%置信区间:0.28-0.97)、有公共保险与私人保险(aOR:0.29,95%置信区间:0.15-0.55)和公共住房与私人住房(aOR:0.59,95%置信区间:0.40-0.87)。
这家城市诊所的临床服务结构调整与病毒抑制率提高有关。然而,并未实施确保保留在医疗保健中的同时干预措施。为了实现终结艾滋病流行的目标,应同时实施保留在医疗保健和病毒抑制的干预措施。保留在医疗保健和病毒抑制的干预措施应进行纵向测量,而不是进行年度的横断面评估,以捕捉这些指标的动态变化。